Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 04, 2018; 91 (10) Article

Assessment and comparison of the max-ICH score and ICH score by external validation

Felix A. Schmidt, Eric M. Liotta, Shyam Prabhakaran, Andrew M. Naidech, Matthew B. Maas
First published August 1, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006117
Felix A. Schmidt
From the Department of Neurology (F.A.S.), Charité - Universitätsmedizin Berlin, Department of Neurology, NeuroCure Clinical Research Center, and the Berlin Institute of Health Berlin, Germany; and Division of Stroke and Critical Care (E.M.L., S.P., A.M.N., M.B.M.), Department of Neurology, Northwestern University, Chicago, IL.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric M. Liotta
From the Department of Neurology (F.A.S.), Charité - Universitätsmedizin Berlin, Department of Neurology, NeuroCure Clinical Research Center, and the Berlin Institute of Health Berlin, Germany; and Division of Stroke and Critical Care (E.M.L., S.P., A.M.N., M.B.M.), Department of Neurology, Northwestern University, Chicago, IL.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shyam Prabhakaran
From the Department of Neurology (F.A.S.), Charité - Universitätsmedizin Berlin, Department of Neurology, NeuroCure Clinical Research Center, and the Berlin Institute of Health Berlin, Germany; and Division of Stroke and Critical Care (E.M.L., S.P., A.M.N., M.B.M.), Department of Neurology, Northwestern University, Chicago, IL.
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew M. Naidech
From the Department of Neurology (F.A.S.), Charité - Universitätsmedizin Berlin, Department of Neurology, NeuroCure Clinical Research Center, and the Berlin Institute of Health Berlin, Germany; and Division of Stroke and Critical Care (E.M.L., S.P., A.M.N., M.B.M.), Department of Neurology, Northwestern University, Chicago, IL.
MD, MSPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew B. Maas
From the Department of Neurology (F.A.S.), Charité - Universitätsmedizin Berlin, Department of Neurology, NeuroCure Clinical Research Center, and the Berlin Institute of Health Berlin, Germany; and Division of Stroke and Critical Care (E.M.L., S.P., A.M.N., M.B.M.), Department of Neurology, Northwestern University, Chicago, IL.
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Short Form
Citation
Assessment and comparison of the max-ICH score and ICH score by external validation
Felix A. Schmidt, Eric M. Liotta, Shyam Prabhakaran, Andrew M. Naidech, Matthew B. Maas
Neurology Sep 2018, 91 (10) e939-e946; DOI: 10.1212/WNL.0000000000006117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
276

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objective We tested the hypothesis that the maximally treated intracerebral hemorrhage (max-ICH) score is superior to the ICH score for characterizing mortality and functional outcome prognosis in patients with ICH, particularly those who receive maximal treatment.

Methods Patients presenting with spontaneous ICH were enrolled in a prospective observational study that collected demographic and clinical data. Mortality and functional outcomes were measured by using the modified Rankin Scale at 3 months. The ICH score and max-ICH score incorporate measures of symptom severity, age, hematoma volume, hematoma location, and intraventricular hemorrhage, with the max-ICH score also including a term for oral anticoagulation and having 16 score categories vs 11 for the ICH score. We compared the area under the receiver operating characteristic curve (AUC) for the ICH score and max-ICH score for both mortality and poor functional outcome, defined as modified Rankin Scale scores 4–6.

Results We analyzed outcomes for 372 patients, including 71 patients (19%) in whom care limitation/withdrawal of life support was instituted. Both the ICH score and max-ICH score showed good prognostic performance for 3-month mortality and poor functional outcomes in the full group as well as the subgroup with maximal treatment (i.e., no care limitations; AUC range 0.80–0.86), with no significant difference in AUC between the scores for either endpoint in either group.

Conclusions External validation with direct comparison of the ICH score and max-ICH score shows that their prognostic performance is not meaningfully different. Alternatives to simple scores are likely needed to improve prognostic estimates for patient care decisions.

Glossary

AUC=
area under the receiver operating characteristic curve;
FOS=
functional outcome score;
GCS=
Glasgow Coma Scale;
ICH=
intracerebral hemorrhage;
mRS=
modified Rankin Scale;
NIHSS=
NIH Stroke Scale;
ROC=
receiver operating characteristic;
TRIPOD=
Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Received July 17, 2017.
  • Accepted in final form June 6, 2018.
  • © 2018 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Glossary
    • Methods
    • Results
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hastening the Diagnosis of Amyotrophic Lateral Sclerosis

Dr. Brian Callaghan and Dr. Kellen Quigg

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Prognosis
  • Outcome research
  • Intracerebral hemorrhage

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Severity assessment in maximally treated ICH patients
    The max-ICH score
    Jochen A. Sembill, Stefan T. Gerner, Bastian Volbers et al.
    Neurology, July 05, 2017
  • Article
    Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage
    Isabel C. Hostettler, Ghil Schwarz, Gareth Ambler et al.
    Neurology, February 24, 2021
  • Article
    The impact of delirium on withdrawal of life-sustaining treatment after intracerebral hemorrhage
    Michael E. Reznik, Scott Moody, Kayleigh Murray et al.
    Neurology, September 10, 2020
  • Article
    Systemic inflammatory response syndrome, infection, and outcome in intracerebral hemorrhage
    Amelia K. Boehme, Mary E. Comeau, Carl D. Langefeld et al.
    Neurology: Neuroimmunology & Neuroinflammation, December 26, 2017
Neurology: 101 (21)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise